Ironwood Pharmaceuticals | IRWD - Actif À Court Terme





Actif À Court Terme Changement Date
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Agios Pharmaceuticals USD 717.67M 117.18M 2026-06
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Almirall EUR 747.1M 33.12M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amarin USD 602.76M 23.26M 2026-06
Ardelyx USD 381.87M 447K 2026-03
Astellas Pharma JPY 1.49T 63.68B 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Charles River Laboratories USD 1.53B 40.3M 2026-06
Coherus Biosciences USD 133.79M 72.25M 2026-06
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Incyte USD 6.03B 542.31M 2026-06
Ironwood Pharmaceuticals USD 332.29M 58.11M 2026-03
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
MacroGenics USD 321.69M 139.16M 2026-06
Moderna USD 5.82B 45M 2026-06
Myriad Genetics USD 289M 23.8M 2026-06
Pacira USD 615.21M 100.25M 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Takeda JPY 3.15T 59.77B 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12